Title: “New Methods and Models to Study Kidney Allograft Rejection”
Dr. Ana Konvalinka
University Health Network
University of Toronto
Date: Friday, December 2, 2022 | 1pm – 2pm EDT
Host: Dr. Darren Yuen
In-Person: Li Ka Shing Knowledge Institute, conference room 216
Join Zoom Meeting (if unable to attend in-person): https://ryerson.zoom.us/j/94939248624?pwd=RW8yNk5SVWF0emtyM1lTMlY0cmdjQT09
LECTURE TAKEAWAYS:
- Antibody-mediated rejection in the kidney allograft is the most important cause of premature kidney allograft loss.
- Analysis and utilization of patient-specific tissue and fluid samples leads to unique insights into disease and may pave the way to precision medicine.
- Cross-disciplinary collaboration has enabled us to build and test new models for disease.
BIOGRAPHY
Dr. Ana Konvalinka is a clinician scientist and transplant nephrologist at the University Health Network in Toronto.
Dr. Konvalinka’s research focuses primarily on antibody-mediated rejection and kidney allograft fibrosis. She utilizes systems biology approaches and proteomics to enhance the understanding of the mechanisms, derive novel markers and to repurpose drugs for treatment of kidney disease.
Dr. Konvalinka’s lecture “New Methods and Models to Study Kidney Allograft Rejection” will discuss how cross-discipline collaboration has enabled researchers to build and test new models for disease, paving the way to precision medicine.
No sign-up is required. For more information, contact the iBEST coordinator (ibest@ryerson.ca).
